SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘United States Anti- 
Doping Agency Reauthorization Act of 2021’’. 
SEC. 2. FINDINGS. 
Congress makes the following findings: 
(1) The United States Anti-Doping Agency— 
(A) is the independent national anti-doping 
organization of the United States; and 
(B) manages the anti-doping program, re-
sults management processes, drug reference re-
sources, and athlete education for all United 
States Olympic Committee-recognized national 
governing bodies and the athletes and events of 
such national governing bodies. 
(2) The United States Anti-Doping Agency con-
tributes to the advancement of clean sport through 
scientific research, anti-doping education, and out-
reach programs, and the mission of the United 
States Anti-Doping Agency is to preserve the integ-
rity of competition and protect the rights of athletes. 
(3) Participation in youth sports has the poten-
tial to equip young athletes with important skills 
and values necessary for success in life, and it is es-
sential that the culture of youth sports emphasizes 
such skills and values.
(4) The TrueSport program of the United 
States Anti-Doping Agency partners with youth 
sport organizations across the United States to pro-
mote sportsmanship, character building, and healthy 
performance through the use of targeted educational 
materials designed to promote a positive youth sport 
experience. 
(5) In modifying the authority of the United 
States Anti-Doping Agency to include the promotion 
of the positive values of youth sport, Congress sends 
a strong signal that the goals of youth sport should 
include instilling in young athletes the values of in-
tegrity, respect, teamwork, courage, and responsi-
bility. 
(6) Due to the unique leadership position of the 
United States in the global community, adequate 
funding of the anti-doping and clean sport programs 
of the United States Anti-Doping Agency is impera-
tive to the preparation for the 2028 Summer Olym-
pic Games, which will be held in Los Angeles, Cali-
fornia. 
(7) Increased appropriations for fiscal years 
2022 through 2030 would enable the United States 
Anti-Doping Agency to directly affect the integrity
and well-being of sport, both domestically and inter-
nationally. 
SEC. 3. MODIFICATIONS OF AUTHORITY. 
Section 701 of the Office of National Drug Control 
Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is 
amended— 
(1) in subsection (b)— 
(A) by amending paragraph (1) to read as 
follows: 
‘‘(1)(A) serve as the independent anti-doping 
organization for the amateur athletic competitions 
recognized by the United States Olympic and 
Paralympic Committee; 
‘‘(B) be responsible for certifying in advance 
any testing conducted by international organizations 
under the World Anti-Doping Code for international 
amateur athletes and athletic competitions occurring 
within the jurisdiction of the United States; and 
‘‘(C) be recognized worldwide as the inde-
pendent national anti-doping organization for the 
United States;’’; 
(B) in paragraph (4), by striking the pe-
riod at the end and inserting ‘‘; and’’; and 
(C) by adding at the end the following:
‘‘(5) promote a positive youth sport experience 
by using a portion of the funding of the United 
States Anti-Doping Agency to provide educational 
materials on sportsmanship, character building, and 
healthy performance for the athletes, parents, and 
coaches who participate in youth sports.’’; and 
(2) by adding at the end the following: 
‘‘(c) 
DUE
PROCESS
IN
ARBITRATION
PRO-
CEEDINGS.—Any action taken by the United States Anti- 
Doping Agency to enforce a policy, procedure, or require-
ment of the United States Anti-Doping Agency against a 
person with respect to a violation of Federal law, including 
an investigation, a disciplinary action, a sanction, or any 
other administrative action, shall be carried out in a man-
ner that provides due process protection to the person.’’. 
SEC. 4. AUTHORIZATION OF APPROPRIATIONS. 
Section 703 of the Office of National Drug Control 
Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is 
amended to read as follows: 
‘‘SEC. 703. AUTHORIZATION OF APPROPRIATIONS. 
‘‘There are authorized to be appropriated to the 
United States Anti-Doping Agency— 
‘‘(1) for fiscal year 2022, $15,500,000; 
‘‘(2) for fiscal year 2023, $16,200,000; 
‘‘(3) for fiscal year 2024, $16,900,000;
‘‘(4) for fiscal year 2025, $17,700,000; 
‘‘(5) for fiscal year 2026, $18,500,000; 
‘‘(6) for fiscal year 2027, $19,800,000; 
‘‘(7) for fiscal year 2028, $22,100,000; 
‘‘(8) for fiscal year 2029, $24,900,000; and 
‘‘(9) for fiscal year 2030, $23,700,000.’’. 
SEC. 5. INFORMATION SHARING. 
Except as otherwise prohibited by law and except in 
cases in which the integrity of a criminal investigation 
would be affected, pursuant to the obligation of the United 
States under Article 7 of the United Nations Educational, 
Scientific, and Cultural Organization International Con-
vention Against Doping in Sport done at Paris October 
19, 2005, and ratified by the United States in 2008, the 
Attorney General, the Secretary of Homeland Security, 
and the Commissioner of Food and Drugs shall provide 
to the United States Anti-Doping Agency any relevant in-
formation relating to the prevention of the use of perform-
ance-enhancing drugs or the prohibition of performance- 
enhancing methods. 
Passed the House of Representatives April 14, 2021. 
Attest: 
Clerk.
117TH CONGRESS 
1ST SESSION 
H. R. 172 
AN ACT 
To reauthorize the United States Anti-Doping 
Agency, and for other purposes.